base metals investing Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
base metals investing Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
base metals investing Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
base metals investing Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug in Early Alzheimer's Disease
Sranan Gold Initiates Diamond Core Drilling Program on the Randy Trend at the Tapanahony Project in Suriname
Silver47 Unveils Multiple Premier Exploration Targets with Strong Discovery Potential Across the Red Mountain Project, Alaska
